FCBR425QF1C30 Bei (USD) [124pcs Hisa]
- 1 pcs$368.42520
- Nambari ya Sehemu:
- FCBR425QF1C30
- Mzalishaji:
- Finisar Corporation
- Maelezo ya kina:
- CBL ASSY 4X25G ETH QSFP 30M. Fiber Optic Cable Assemblies 4x25G, full-duplex, Ethernet, QSFP cable ends, electrical limiting interface, RoHS, multimode, 2.5W, 0/70 C operation. Internal optics: 850nm VCSEL array, PIN array, round
- Manufacturer's standard lead time:
- Katika hisa
- Maisha ya rafu:
- Mwaka mmoja
- Chip Kutoka:
- Hong Kong
- RoHS:
- Njia ya malipo:
-
- Njia ya usafirishaji:
- Jamii Jamii:
- VITAMBUZI VYA Co, LTD ni Msambazaji wa Vipengele vya Elektroniki ambavyo hutoa aina za bidhaa pamoja na: Kati ya kabati za Adapter za mfululizo, Mabati ya Flat Flex (FFC, FPC), Flat Flex, Ribbon Jumper Cables, Waya za jumper, inaongoza kabla, Mabango ya Coaxial (RF), Mabango ya USB, Mabango ya Firewire (IEEE 1394) and Mabango ya kawaida ...
- Faida ya Ushindani:
- We specialize in Finisar Corporation FCBR425QF1C30 electronic components. FCBR425QF1C30 can be shipped within 24 hours after order. If you have any demands for FCBR425QF1C30, Please submit a Request for Quotation here or send us an email: rfq@key-components.com
FCBR425QF1C30 Sifa za Bidhaa
Nambari ya Sehemu :
FCBR425QF1C30
Mzalishaji :
Finisar Corporation
Maelezo :
CBL ASSY 4X25G ETH QSFP 30M
Mfululizo :
-
Hali ya Sehemu :
Active
Viunga vya Cable :
-
Idadi ya Nafasi :
-
Aina ya kiunganishi :
-
Jinsia :
-
Aina ya kufunga :
-
Vipengele :
-
Aina ya Cable :
-
Matumizi :
-
Urefu :
-
Rangi :
-
Kuvimba :
-
Habari mpya kabisa
Unaweza pia Kuvutiwa Na
-
-
-
-
FCCN410QD3CX0
Finisar Corporation
CABLE QSFP M-M 100M. Fiber Optic Cable Assemblies Fiber Optic Cable Assemblies
-
FCBN425QB1C03
Finisar Corporation
CABLE QSFP28 M-M 3M. Fiber Optic Cable Assemblies 100G QSFP28 QSFP AOC
-
FCBN425QB1C05
Finisar Corporation
CABLE QSFP28 M-M 5M. Fiber Optic Cable Assemblies 100G QSFP28 QSFP AOC
Sehemu za Moto
- 6A44-B0421-027.0-0
- FCBG414QB1C07
- FCBG125SD1C10
- 0887614610
- 1003453301
- 0747521108
- 0745472061
- 6A22-D0421-021.0-0
- 1003451151
- ICD056GVP163D-70
- FCBN425QD1C03
- 1003451051
- PCIEC-036-0250-EC-EC
- 6A11-A0141-026.0-0
- 6A11-A0121-017.0-0
- ICD150GVP341A-10
- AK-ESATA-SB1-R
- 0745470003
- 6A11-A0141-020.0-0
- 10018960-N1000AULF
- 6A22-A0441-090.0-0
- 10087902-066RLF
- 1064152005
- ICD150GVP244H-10
- 0795763008
- FCBR425QD1C30
- 6A22-A0441-029.0-0
- 10126213-A02502JLF
- ICD150GVP2410-02
- 6A44-B0421-080.0-0
- 1110404505
- 1110251300
- ICD056GVP163D-15
- ICD120GVP2420-50
- 1110251209
- 6A44-B0441-080.0-0
- 10115005-7SR910HLF
- 10115005-7SR545HLF
- 10115441-15R075HLF
- 10115441-15R135HLF